Inflammatory Cells in Nephrectomy Tissue from Patients without and with a History of Urinary Stone Disease

Authors: Dejban, Pegah, Wilson, Elena M., Jayachandran, Muthuvel, Herrera Hernandez, Loren P., Haskic, Zejfa, Wellik, Linda E., Sinha, Sutapa, Rule, Andrew D., Denic, Aleksandar, Koo, Kevin, Potretzke, Aaron M., Lieske, John C.

Source: Clinical journal of the American Society of Nephrology. 17(3):414-422

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100192342909.0x000001&indx=1&recIds=ETOCvdc_100192342909.0x000001

Increased glutathione utilization augments tumor cell proliferation in Waldenstrom Macroglobulinemia

Authors: Jalali, Shahrzad, Shi, Jie, Buko, Alex, Ahsan, Nagib, Paludo, Jonas, Serres, Makayla, Wellik, Linda E., Abeykoon, Jithma, Kim, HyoJin, Tang, Xinyi, Yang, Zhi-Zhang, Novak, Anne J., Witzig, Thomas E., Ansell, Stephen M.

Source: In Redox Biology September 2020 36

Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.

Authors: Sinha, Sutapa, Guo, Ray, Del Busso, Miles D., Han, Weiguo, Boysen, Justin, Wellik, Linda E., Ghosh, Asish K., Kay, Neil E.

Source: British Journal of Cancer; Aug2024, Vol. 131 Issue 3, p589-600, 12p

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Authors: Ding, Wei, LaPlant, Betsy R., Call, Timothy G., Parikh, Sameer A., Leis, Jose F., He, Rong, Shanafelt, Tait D., Sinha, Sutapa, Le-Rademacher, Jennifer, Feldman, Andrew L., Habermann, Thomas M., Witzig, Thomas E., Wiseman, Gregory A., Lin, Yi, Asmus, Erik, Nowakowski, Grzegorz S., Conte, Michael J., Bowen, Deborah A., Aitken, Casey N., Van Dyke, Daniel L., Greipp, Patricia T., Liu, Xin, Wu, Xiaosheng, Zhang, Henan, Secreto, Charla R., Tian, Shulan, Braggio, Esteban, Wellik, Linda E., Micallef, Ivana, Viswanatha, David S., Yan, Huihuang, Chanan-Khan, Asher A., Kay, Neil E., Dong, Haidong, Ansell, Stephen M.

Source: In Blood 29 June 2017 129(26):3419-3427

Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach.

Authors: Le, Kang, Vollenweider, Jordan, Han, JingJing, Staudinger, Nicholas, Stenson, Mary, Bayraktar, Lara, Wellik, Linda E., Maurer, Matthew J., McPhail, Ellen D., Witzig, Thomas E., Gupta, Mamta

Source: Hematological Oncology; Jan2024, Vol. 42 Issue 1, p1-13, 13p

Subject Terms: T-cell lymphoma, PROTEIN-tyrosine phosphatase, MYELOPROLIFERATIVE neoplasms, IMMUNOHISTOCHEMISTRY, STAT proteins, CRIZOTINIB

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Authors: Wang, Tianjiao, Feldman, Andrew L., Wada, David A., Lu, Ye, Polk, Avery, Briski, Robert, Ristow, Kay, Habermann, Thomas M., Thomas, Dafydd, Ziesmer, Steven C., Wellik, Linda E., Lanigan, Thomas M., Witzig, Thomas E., Pittelkow, Mark R., Bailey, Nathanael G., Hristov, Alexandra C., Lim, Megan S., Ansell, Stephen M., Wilcox, Ryan A.

Source: In Blood 8 May 2014 123(19):3007-3015

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

Authors: Gupta, Mamta ^*, Maurer, Matthew J., Wellik, Linda E., Law, Mark E., Han, Jing Jing, Ozsan, Nazan, Micallef, Ivana N., Dogan, Ahmet, Witzig, Thomas E.

Source: In Blood 22 November 2012 120(22):4400-4406

Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies

Authors: Gupta, Mamta ^*, Hendrickson, Andrea E. Wahner ^*, Yun, Seong Seok, Han, Jing Jing, Schneider, Paula A., Koh, Brian D., Stenson, Mary J., Wellik, Linda E., Shing, Jennifer C., Peterson, Kevin L., Flatten, Karen S., Hess, Allan D., Smith, B. Douglas, Karp, Judith E., Barr, Sharon, Witzig, Thomas E., Kaufmann, Scott H.

Source: In Blood 12 January 2012 119(2):476-487

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells

Authors: Ghosh, Asish K., Shanafelt, Tait D., Cimmino, Amelia, Taccioli, Cristian, Volinia, Stefano, Liu, Chang-gong, Calin, George A., Croce, Carlo M., Chan, Denise A., Giaccia, Amato J., Secreto, Charla, Wellik, Linda E., Lee, Yean K., Mukhopadhyay, Debabrata, Kay, Neil E.

Source: In Blood 28 May 2009 113(22):5568-5574

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

Authors: Wang, Yucai, Sinha, Sutapa, Wellik, Linda E., Secreto, Charla R., Rech, Karen L., Call, Timothy G., Parikh, Sameer A., Kenderian, Saad S., Muchtar, Eli, Hayman, Suzanne R., Koehler, Amber B., Van Dyke, Daniel L., Leis, Jose F., Slager, Susan L., Dong, Haidong, Kay, Neil E., He, Rong, Ding, Wei

Source: Blood Cancer Journal; May2021, Vol. 11 Issue 5, p1-9, 9p

Subject Terms: CHRONIC lymphocytic leukemia, RICHTER syndrome, PROTEIN expression, IMMUNE checkpoint inhibitors, MACROPHAGES

JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.

Authors: Le, Kang, Wellik, Linda E., Maurer, Matthew J., McPhail, Ellen D., Witzig, Thomas E., Gupta, Mamta

Source: Blood Cancer Journal; Mar2021, Vol. 11 Issue 3, p1-5, 5p

Subject Terms: NEOPLASTIC cell transformation, NON-coding RNA, CANCER genetics

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Elevated Soluble IL-2Ra Levels Are Associated With Inferior Outcome and Is Independent Of MIPI Score in Patients With Mantle Cell Lymphoma

Authors: Bassam, Mohamad ^*, Maurer, Matthew J ^*, Stenson, Mary ^*, Wellik, Linda E ^*, Allmer, Christine ^*, Link, Brian K, Cerhan, James R, Witzig, Thomas E ^*, Gupta, Mamta

Source: In Blood 15 November 2013 122(21):4256-4256

In-Vivo Activation Of STAT3 In Angioimmunoblastic T Cell Lymphoma, PTCL Not Otherwise Specified, and ALK Negative Anaplastic Large Cell Lymphoma: Implications For Therapy

Authors: Gupta, Mamta, Maurer, Matthew J. ^*, Stenson, Mary ^*, Wellik, Linda E. ^*, Han, Jing Jing ^*, Feldman, Andrew L., Habermann, Thomas M., Witzig, Thomas E. ^*

Source: In Blood 15 November 2013 122(21):844-844

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Authors: Wang, Tianjiao ^*, Feldman, Andrew L., Wada, David A ^*, Lu, Ye ^*, Polk, Avery ^*, Briski, Robert ^*, Ristow, Kay M. ^*, Habermann, Thomas M, Thomas, Dafydd G ^*, Ziesmer, Steven C. ^*, Wellik, Linda E ^*, Lanigan, Thomas ^*, Witzig, Thomas E ^*, Pittelkow, Mark ^*, Bailey, Nathanael G., Lim, Megan, Ansell, Stephen M, Wilcox, Ryan A.

Source: In Blood 15 November 2013 122(21):841-841

Repression Of Cap-Dependent Translation With a Next-Generation mTOR Inhibitor Attenuates c-Myc Transcription and Survival In Lymphoma Cells

Authors: Gupta, Mamta, Han, Jing Jing ^*, Stenson, Mary ^*, Wellik, Linda E ^*, Witzig, Thomas E ^*

Source: In Blood 15 November 2013 122(21):636-636

SHP1 Suppression In Diffuse Large B Cell Lymphoma Is Regulated Through Promoter Hypermethylation At Novel CpG2 Island and H3K27 Trimethylation Histone Mark

Authors: Gupta, Mamta, Hu, Guangzhen ^*, Wellik, Linda E ^*, Han, Jing Jing ^*, Stenson, Mary ^*, Dogan, Ahmet, Witzig, Thomas E ^*

Source: In Blood 15 November 2013 122(21):632-632